These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48 related articles for article (PubMed ID: 1823317)
1. Recombinant gp120 specifically enhances tumour necrosis factor-alpha production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors. Dis Markers; 1991; 9(6):342-4. PubMed ID: 1823317 [No Abstract] [Full Text] [Related]
2. Recombinant gp120 specifically enhances tumor necrosis factor-alpha production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors. Rieckmann P; Poli G; Fox CH; Kehrl JH; Fauci AS J Immunol; 1991 Nov; 147(9):2922-7. PubMed ID: 1918999 [TBL] [Abstract][Full Text] [Related]
3. gp120- and TNF-alpha-induced modulation of human B cell function: proliferation, cyclic AMP generation, Ig production, and B-cell receptor expression. Patke CL; Shearer WT J Allergy Clin Immunol; 2000 May; 105(5):975-82. PubMed ID: 10808179 [TBL] [Abstract][Full Text] [Related]
4. The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion. Clouse KA; Cosentino LM; Weih KA; Pyle SW; Robbins PB; Hochstein HD; Natarajan V; Farrar WL J Immunol; 1991 Nov; 147(9):2892-901. PubMed ID: 1918997 [TBL] [Abstract][Full Text] [Related]
5. CD4-imitating human antibodies in HIV infection and anti-idiotypic vaccination. Deckert PM; Ballmaier M; Lang S; Deicher H; Schedel I J Immunol; 1996 Jan; 156(2):826-33. PubMed ID: 8543839 [TBL] [Abstract][Full Text] [Related]
6. Are blockers of gp120/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis? Herbeuval JP; Shearer GM AIDS Rev; 2006; 8(1):3-8. PubMed ID: 16736946 [TBL] [Abstract][Full Text] [Related]
7. Binding of HIV-1 virions or gp120-anti-gp120 immune complexes to HIV-1-infected quiescent peripheral blood mononuclear cells reveals latent infection. Briant L; Coudronnière N; Robert-Hebmann V; Benkirane M; Devaux C J Immunol; 1996 May; 156(10):3994-4004. PubMed ID: 8621941 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of a V2 epitope in clade B primary isolates and its recognition by sera from HIV-1-infected individuals. Israel ZR; Gorny MK; Palmer C; McKeating JA; Zolla-Pazner S AIDS; 1997 Jan; 11(1):128-30. PubMed ID: 9110092 [No Abstract] [Full Text] [Related]
9. Neutralization of divergent HIV-1 isolates by conformation dependent human antibodies to gp120. Dis Markers; 1991; 9(6):344-5. PubMed ID: 1823318 [No Abstract] [Full Text] [Related]
10. Induction of IFN-alpha by HIV-1 in monocyte-enriched PBMC requires gp120-CD4 interaction but not virus replication. Francis ML; Meltzer MS J Immunol; 1993 Aug; 151(4):2208-16. PubMed ID: 8345204 [TBL] [Abstract][Full Text] [Related]
11. Tumour necrosis factor-alpha increases the sensitivity of human immunodeficiency virus (HIV)-infected monocytic U937 cells to the complement-dependent cytotoxicity of sera from HIV type 1-infected individuals; role of the gp120 protein. Szabò B; Locardi C; Lo Presti E; Belardelli F; Benedetto A J Gen Virol; 1993 Jul; 74 ( Pt 7)():1271-6. PubMed ID: 8336118 [TBL] [Abstract][Full Text] [Related]
12. The effects of the HIV-1 envelope protein gp120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures. Kong LY; Wilson BC; McMillian MK; Bing G; Hudson PM; Hong JS Cell Immunol; 1996 Aug; 172(1):77-83. PubMed ID: 8806809 [TBL] [Abstract][Full Text] [Related]
13. Monocytotoxic antibodies in HIV-infected persons. TNF-alpha treatment of U937 cells increases the complement dependent cytotoxicity. Szabó B; Locardi C; Lo Presti E; Benedetto A; Belardelli F Acta Microbiol Hung; 1993; 40(3):191-200. PubMed ID: 8191865 [TBL] [Abstract][Full Text] [Related]
14. Complement activation by recombinant HIV-1 glycoprotein gp120. Süsal C; Kirschfink M; Kröpelin M; Daniel V; Opelz G J Immunol; 1994 Jun; 152(12):6028-34. PubMed ID: 7911492 [TBL] [Abstract][Full Text] [Related]
15. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1. Bower JF; Green TD; Ross TM Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens. Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590 [TBL] [Abstract][Full Text] [Related]
17. SDF-1alpha regulates HIV-1-gp120-induced changes in CD79b surface expression and Ig production in activated human B cells. Nance CL; Shearer WT Clin Immunol; 2002 Nov; 105(2):208-14. PubMed ID: 12482395 [TBL] [Abstract][Full Text] [Related]
18. Membrane tumour necrosis factor-alpha is involved in the polyclonal B-cell activation induced by HIV-infected human T cells. Macchia D; Almerigogna F; Parronchi P; Ravina A; Maggi E; Romagnani S Nature; 1993 Jun; 363(6428):464-6. PubMed ID: 7684824 [TBL] [Abstract][Full Text] [Related]
19. Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies. Ahmad A; Ladha A; Cohen EA; Menezes J Virology; 1993 Feb; 192(2):447-57. PubMed ID: 8421893 [TBL] [Abstract][Full Text] [Related]
20. Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66. Manca F; Fenoglio D; Valle MT; Li Pira G; Kunkl A; Ferraris A; Saverino D; Lancia F; Mortara L; Lozzi L J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):227-37. PubMed ID: 7540488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]